151 related articles for article (PubMed ID: 20418225)
1. HER-2/NEU overexpression in vulvar Paget disease: the Yale experience.
Richter CE; Hui P; Buza N; Silasi DA; Azodi M; Santin AD; Schwartz PE; Rutherford TJ
J Clin Pathol; 2010 Jun; 63(6):544-7. PubMed ID: 20418225
[TBL] [Abstract][Full Text] [Related]
2. HER-2/neu expression in Paget disease of the vulva and the female breast.
Brummer O; Stegner HE; Böhmer G; Kühnle H; Petry KU
Gynecol Oncol; 2004 Nov; 95(2):336-40. PubMed ID: 15491754
[TBL] [Abstract][Full Text] [Related]
3. HER-2 gene amplification in Paget disease of the nipple and extramammary site: a chromogenic in situ hybridization study.
Bianco MK; Vasef MA
Diagn Mol Pathol; 2006 Sep; 15(3):131-5. PubMed ID: 16932067
[TBL] [Abstract][Full Text] [Related]
4. COX-2 and Her-2/neu are overexpressed in Paget's disease of the vulva and the breast: results of a preliminary study.
Horn LC; Purz S; Krumpe C; Bilek K
Arch Gynecol Obstet; 2008 Feb; 277(2):135-8. PubMed ID: 17701193
[TBL] [Abstract][Full Text] [Related]
5. [Intralesional interferon in the treatment of extramammary Paget's disease].
Kobayashi H; Someda Y; Furukawa M; Chanoki M; Hamada T
Nihon Hifuka Gakkai Zasshi; 1987 Jan; 97(1):1-7. PubMed ID: 3033357
[No Abstract] [Full Text] [Related]
6. [Expression status of HER2 in mammary and extramammary Paget's disease].
Meng H; Zheng XY; Zhang L; Li WC
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):255-6. PubMed ID: 21616001
[No Abstract] [Full Text] [Related]
7. GATA3 expression in primary vulvar Paget disease: a potential pitfall leading to misdiagnosis of pagetoid urothelial intraepithelial neoplasia.
Morbeck D; Tregnago AC; Baiocchi G; Sacomani C; Peresi PM; Osório CT; Schutz L; Bezerra SM; de Brot L; Cunha IW
Histopathology; 2017 Feb; 70(3):435-441. PubMed ID: 27633145
[TBL] [Abstract][Full Text] [Related]
8. [Micro-invasive vulvar Paget's disease and lymph node metastasis: a same disease?].
Quintyn-Ranty ML; Escourrou G; Paute A; Viale J; Guilbeau C; Delisle MB
Ann Pathol; 2011 Oct; 31(5):341-4. PubMed ID: 21982239
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of the vulvar Paget's disease: report of 8 cases].
Yamashiro T; Teshima H; Yokosuka K; Shimizu Y; Hirai Y; Chen JT; Fujimoto I; Hasumi K; Masubuchi K; Sakamoto A
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2563-8. PubMed ID: 2482320
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for recurrence and survival among patients with invasive vulvar Paget disease included in the VULCAN study.
Iacoponi S; Zalewski K; Fruscio R; Diaz-De la Noval B; De Iaco P; Ceccaroni M; Barazi D; Chen F; Zapardiel I;
Int J Gynaecol Obstet; 2016 Apr; 133(1):76-9. PubMed ID: 26861886
[TBL] [Abstract][Full Text] [Related]
11. HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature review.
Karam A; Berek JS; Stenson A; Rao J; Dorigo O
Gynecol Oncol; 2008 Dec; 111(3):568-71. PubMed ID: 18252264
[TBL] [Abstract][Full Text] [Related]
12. p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget's disease.
Reich O; Liegl B; Tamussino K; Regauer S
Mod Pathol; 2005 Mar; 18(3):354-7. PubMed ID: 15272283
[TBL] [Abstract][Full Text] [Related]
13. Paget's disease of the vulva: Diagnosis and follow-up key to management; a retrospective study of 50 cases from Queensland.
Jones IS; Crandon A; Sanday K
Gynecol Oncol; 2011 Jul; 122(1):42-4. PubMed ID: 21501860
[TBL] [Abstract][Full Text] [Related]
14. The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget's disease.
Garganese G; Inzani F; Mantovani G; Santoro A; Valente M; Babini G; Petruzzellis G; Fragomeni SM; Gentileschi S; Bove S; Franchi M; Angelico G; Fagotti A; Scambia G; Zannoni GF
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2211-2225. PubMed ID: 31297606
[TBL] [Abstract][Full Text] [Related]
15. Non-human-papillomavirus-related malignancies of the vulva: A clinicopathological study.
Furlan K; Rohra P; Mir F; Gattuso P
J Cutan Pathol; 2020 Oct; 47(10):917-922. PubMed ID: 32511773
[TBL] [Abstract][Full Text] [Related]
16. Extramammary Paget's disease arising in a mature cystic teratoma of the ovary: immunohistochemical expression of androgen receptor.
Shintaku M; Nakagawa E; Tsubura A
Pathol Int; 2011 Aug; 61(8):498-500. PubMed ID: 21790867
[No Abstract] [Full Text] [Related]
17. Immunohistochemical study of HER2 and TUBB3 proteins in extramammary Paget disease.
Miyamoto A; Akasaka K; Oikawa H; Akasaka T; Masuda T; Maesawa C
Am J Dermatopathol; 2010 Aug; 32(6):578-85. PubMed ID: 20534991
[TBL] [Abstract][Full Text] [Related]
18. HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy.
Plaza JA; Torres-Cabala C; Ivan D; Prieto VG
J Cutan Pathol; 2009 Jul; 36(7):729-33. PubMed ID: 19519604
[TBL] [Abstract][Full Text] [Related]
19. Cytologic detection of recurrence in extramammary Paget's disease of the vulva: a report of two cases.
Tanaka Y; Kirihara T; Kitamura H; Kuriyama M; Hori H; Gorai I
Acta Cytol; 2010; 54(5 Suppl):1007-12. PubMed ID: 21053588
[TBL] [Abstract][Full Text] [Related]
20. A Case of Chronic and Relapsing Paget Disease of the Vulva.
Bouceiro-Mendes R; Mendonça-Sanches M; Soares-de-Almeida L; Correia-Fonseca I
Rev Bras Ginecol Obstet; 2019 Jun; 41(6):412-416. PubMed ID: 31018229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
